HTG Molecular Diagnostics, Inc. Deferred Revenue
HTG Molecular Diagnostics, Inc. had Deferred Revenue of $665.88 thousand as of 2017-12-31, per its 10-K filed 2018-03-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-03-23
- 2017-12-31: Deferred Revenue, Current $665.88K.
- 2017-09-30: Deferred Revenue, Current $780.97K.
- 2017-06-30: Deferred Revenue, Current $637.93K.
- 2017-03-31: Deferred Revenue, Current $255.48K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-12-31 | $665.88K 10-K · filed 2018-03-23 |
| 2017-09-30 | $780.97K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $637.93K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $255.48K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $335.66K 10-K · filed 2018-03-23 |
| 2016-09-30 | $283.66K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $183.71K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $25.45K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $47.48K 10-K · filed 2017-03-23 |
| 2015-09-30 | $32.72K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $28.75K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $32.02K 10-Q · filed 2015-06-08 |
| 2014-12-31 | $41.25K 10-K · filed 2016-03-25 |